|
Originally published In Press as doi:10.1074/jbc.M001536200 on July 11, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32763-32768, October 20, 2000
Light Intermediate Chain 1 Defines a Functional Subfraction of
Cytoplasmic Dynein Which Binds to Pericentrin*
Sharon H.
Tynan ,
Aruna
Purohit§,
Stephen J.
Doxsey §, and
Richard B.
Vallee ¶
From the Department of Cell Biology and the
§ Program in Molecular Medicine, University of Massachusetts
Medical Center, Worcester, Massachusetts 01605
Received for publication, February 24, 2000, and in revised form, June 27, 2000
 |
ABSTRACT |
The light intermediate chains (LICs) of
cytoplasmic dynein consist of multiple isoforms, which undergo
post-translational modification to produce a large number of species
separable by two-dimensional electrophoresis and which we have proposed
to represent at least two gene products. Recently, we demonstrated the
first known function for the LICs: binding to the centrosomal protein,
pericentrin, which represents a novel, non-dynactin-based cargo-binding
mechanism. Here we report the cloning of rat LIC1, which is
approximately 75% homologous to rat LIC2 and also contains a P-loop
consensus sequence. We compared LIC1 and LIC2 for the ability to
interact with pericentrin, and found that only LIC1 will bind. A
functional P-loop sequence is not required for this interaction. We
have mapped the interaction to the central region of both LIC1 and
pericentrin. Using recombinant LICs, we found that they form
homooligomers, but not heterooligomers, and exhibit mutually exclusive
binding to the heavy chain. Additionally, overexpressed pericentrin is
seen to interact with endogenous LIC1 exclusively. Together these
results demonstrate the existence of two subclasses of cytoplasmic
dynein: LIC1-containing dynein, and LIC2-containing dynein, only the
former of which is involved in pericentrin association with dynein.
 |
INTRODUCTION |
Cytoplasmic dynein is a large, multi-subunit complex (1), which
functions as a molecular motor that moves cellular components toward
the minus ends of microtubules and determines the distribution of many
vesicular organelles (2). Cytoplasmic dynein has also been found to be
involved in many aspects of mitosis, where it is found at the
kinetochore, spindle poles, and cell cortex (3-7).
The cytoplasmic dynein complex is composed of four subunit classes: the
heavy (HCs),1 intermediate
(ICs), light intermediate (LICs), and light chains (LCs). The dynein
heavy chains are large (532 kDa) polypeptides that contain four ATPase
domains and are responsible for microtubule binding and catalytic
activity (2). The intermediate chains are a diverse set of subunits
derived by alternative splicing from two different genes (8). The ICs
have been found to be responsible for the interaction of the dynein
complex with a second complex called dynactin, which is required for
dynein-based motility, by directly binding to the p150Glued
dynactin subunit (8, 9). Dynactin is thought to be involved in linking
dynein to various organelles in the cell; thus the intermediate chains
have been proposed to have an important function in dynein targeting
(7). The LCs are a diverse family of low and very low molecular weight
subunits (10-12); a role in subcellular targeting has been proposed
(13).
The HCs, ICs, and LCs all have homologous counterparts in flagellar and
ciliary forms of dynein. The LICs, however, are unique to cytoplasmic
dynein. They contain a P-loop consensus sequence of unknown function
(14, 15). Two-dimensional electrophoresis of both rat and chicken LICs
reveals numerous LIC species, at least some of which result from
phosphorylation of the LIC polypeptides (14, 15). Based on molecular
cloning of one of the rat LICs and peptide microsequencing, we proposed
that there are at least two different LIC genes per organism (15).
Comparison of the chicken sequence, DLC-A, to the sequence of our rat
LIC2 clones and bovine LIC peptide sequences suggests that DLC-A is the
chicken isoform of LIC1 and that LIC1 and LIC2 are different gene
products (15). Northern blotting suggests that both LICs have a wide tissue distribution (14, 15).
Recently, we demonstrated that recombinant full-length and truncated
LIC polypeptides bind to pericentrin, a structural component of the
centrosome that is thought to be involved in organizing microtubule
nucleating material. Pericentrin has been observed to move in a linear
fashion along microtubules toward the centrosome (16). Quantitative
analysis of centrosomal components during the cell cycle indicated that
pericentrin, along with -tubulin, accumulates from
G1 through metaphase, at which time the centrosomal level drops dramatically (17), although somewhat different results have
been reported for -tubulin in a different system (18). Using a
co-overexpression and immunoprecipitation assay, we tested a number of
dynein and dynactin subunits for the ability to bind to pericentrin. Of
all the expression constructs used, only full-length and truncated LIC
were found to co-immunoprecipitate with overexpressed pericentrin.
Furthermore, when we repeated this experiment in 35S-labeled cells, pericentrin and a LIC fragment were the
only specific immunoprecipitated species detected, demonstrating a direct interaction. These results suggest that the LICs, like the ICs,
are responsible for linking dynein to its cargo.
In this study, we report the cDNA cloning and sequencing of rat
LIC1, establishing the existence of two LIC genes, and we compare the
ability of both LIC1 and LIC2 to bind to pericentrin. We find that
LIC1, but not LIC2, is capable of this interaction, and we have
identified the central portions of both LIC1 and pericentrin as the
interacting regions. To determine whether a distinct
pericentrin-binding form of the dynein complex exists, we examined the
LIC content of dynein and have found that the LICs form homooligomers,
but not heterooligomers, and that in triple overexpression studies, HC
can bind to either LIC1 or LIC2, but not both. Furthermore, endogenous
LIC1, but not LIC2, co-immunoprecipitates with overexpressed pericentrin. These results indicate that the LICs specify different subtypes of dynein, only one of which interacts with pericentrin.
 |
EXPERIMENTAL PROCEDURES |
cDNA Cloning and Sequencing--
A rat brain cDNA
library in the Lambda ZAP II vector (Stratagene, La Jolla, CA) was
screened by plaque hybridization as described previously (15) with
probes random-primed (DECAprime II kit, Ambion, Inc., Austin, TX) from
rat LIC2 cDNA (15). Isolated cDNA clones were sequenced
(Sequenase, version 2.0, Amersham Pharmacia Biotech) and compared with
LIC peptide and LIC2 cDNA sequence (15). We identified one LIC1
cDNA and used probes random-primed from it to isolate additional
LIC1 cDNAs from the library. The 5'-end of the cDNA was
obtained using the Marathon cDNA amplification kit with rat brain
mRNA (CLONTECH, Palo Alto, CA). The entire LIC1
cDNA sequence was assembled and analyzed using the GCG DNA analysis
programs, including BESTFIT and PILEUP. The National Center for
Biotechnology Information (NCBI) data bases were scanned using BLAST
(19).
Mammalian Expression Constructs--
LIC1 and LIC2 mammalian
expression constructs (see Fig. 3) were made by removing the -gal
sequence from pCMV (CLONTECH) with
NotI (New England BioLabs, Beverly, MA) digestion and
inserting LIC1 and LIC2 full-length or partial cDNAs. The LIC
cDNAs had 3'-end NotI sites and coding sequence for
epitope tags: myc (MEQKLISEEDLN), HA (YPYPVPDYA), or
FLAG (DYKDDDDK) added by PCR. NotI restriction sites were
added to the 5'-ends by either PCR or cloning into pARK (gift from Dr.
Melissa Gee), which has NotI sites flanking the MCS. LIC1
P-loop point mutations were made using the Chameleon double-stranded,
site-directed mutagenesis kit (Stratagene). To produce an
amino-terminal fragment of pericentrin (pHAI/pericentrin 1-575), we
cut the full-length HA-pericentrin construct (20) with
PaeR7I creating a clone extending from the start
codon (nucleotide 295) to nucleotide 2019. A truncated central domain
of pericentrin containing nucleotides 2587-4317 of the full-length
pericentrin was constructed (pHAI/pericentrin 764-1341) by PCR
amplification using clone lambda Pc1.2 (21), a 5'-primer with a
5'-EcoRI restriction enzyme site
(5'-GCGAATTCCTGAAACGCCAACAT3-') and a 3'-primer with a
3'-PaeR7I site (5'-CGATTTCCTCTGCTTTATCC3-'). The PCR product was digested with EcoRI and PaeR7I and ligated
into the pHAI plasmid digested with EcoRI/PaeR7I.
A third truncated form of pericentrin coding for the carboxyl terminus
(pHAI/pericentrin 1341-1920) was constructed by digesting lambda pc1.2
with XbaI. The restriction fragment was cut by
PaeR7I and inserted into pHAI to yield a clone containing
nucleotides 4317-6309, with a stop codon at nucleotide 6054.
Antibodies--
The LIC1 and LIC2 cDNAs were put into the
NdeI site of pET 15b (Novagen, Inc., Madison, WI) expression
vector and expressed in Escherichia coli strain BL21DE3. The
bacteria were lysed by French press, and the cell debris was pelleted.
The bacterial cytoplasm was passed over a nickel affinity column
(Novagen), washed, and eluted with imidazole (Sigma). The eluates were
dialyzed into Dulbecco's phosphate-buffered saline and concentrated in Slide-A-Lyzer dialysis cassettes (Pierce, Rockford, IL). The recovered proteins were conjugated to preactivated keyhole limpet
hemocyanin (Pierce), mixed with Freund's complete or incomplete
adjuvant (Pierce) and injected into New Zealand White rabbits
(Millbrook Farms, Amherst, MA). After the initial injections and two
more boosts, blood was collected and the sera were tested against COS-7 cell extract on immunoblots (7).
Anti-myc polyclonal antibody used was described previously (22);
anti-HA polyclonal and monoclonal antibodies were purchased from BAbCO
(Richmond, CA); and anti-FLAG M2 monoclonal antibody and affinity resin
were purchased from Sigma. Secondary horseradish peroxidase-conjugated
donkey anti-mouse and anti-rabbit antibodies were purchased from
Jackson Immunoresearch Labs, Inc. (West Grove, PA).
Co-immunoprecipitation Assays--
COS-7 cells were grown in
Dulbecco's modified Eagle's medium (Life Technologies, Inc., Grand
Island, NY) supplemented with 10% fetal calf serum and
penicillin/streptomycin (Life Technologies, Inc.). The cells were
transfected (LipofectAMINE, Life Technologies, Inc.) for 6-12 h with
1-4 µg of DNA. Transfections were individually optimized for each
construct and combinations of constructs. 30-48 h after transfection,
the cells were harvested by washing the monolayer twice with
Dulbecco's phosphate-buffered saline and scraping into modified RIPA
buffer (100 mM NaCl, 1 mM EGTA, 50 mM Tris, pH 8.0, 1 mM Pefabloc SC (Roche
Molecular Biochemicals), and 2 µg/ml leupeptin and pepstatin).
The cells were placed in a microcentrifuge tube on ice for 20 min and then spun in a microcentrifuge at maximum speed for 10 min. The
resulting extract was used for all co-immunoprecipitation experiments
with protein G (Amersham Pharmacia Biotech)- or protein A
(Pierce)-Sepharose beads and the appropriate antibody.
Immunoprecipitations were incubated overnight at 4 °C with gentle
agitation. The beads were then washed with modified RIPA buffer five
times at room temperature and eluted into 2× SDS-polyacrylamide gel
electrophoresis sample buffer at 100 °C for 5 min. The entire eluate
and a sample of the supernatant were used for immunoblotting.
Co-transfection efficiency was determined by double indirect
immunofluorescence microscopy and varied considerably between
combinations of constructs. When extracts from singly transfected
cultures were mixed, co-precipitation was never observed, indicating
that interactions between co-expressed proteins occurred in
vivo.
Co-immunoprecipitation of overexpressed pericentrin and endogenous LICs
was performed essentially as described above, with the following
change: the beads were eluted with 2× SDS-polyacrylamide gel
electrophoresis sample buffer, which did not contain
-mercaptoethanol, at 100 °C for 5 min.
 |
RESULTS |
LIC1 cDNA Cloning and Sequencing--
Bovine LIC peptide
sequences generated in our earlier study (15) included one LIC1
(indicated as LIC 57/59 in the previous manuscript) peptide sequence
that was unique but corresponded to part of the deduced sequence from
chicken DLC-A, suggesting the existence of a second LIC gene in rat. To
test this possibility, we isolated additional LIC cDNAs from a rat
brain cDNA library; we identified a novel cDNA clone, which we
termed LIC1. Two different mRNAs were represented among LIC1 clones
obtained; they differed only in their polyadenylation site, consistent
with what was reported for chicken DLC-A (14). The complete cDNA
sequence of rat LIC1 has been deposited (GenBankTM accession number
AF181992). A line diagram of the two rat LICs is shown in Fig.
1A. Using BESTFIT, we find rat
LIC1 to be 65% identical (71% similar) to rat LIC2 and 81% identical
(90.8% similar) to DLC-A. The sequences are closely related throughout
the entire length, with the greatest divergence being at the ends. Fig.
1A shows the location of the peptide sequences that we
reported previously (15). Two of the LIC2-derived peptides do not have
homologous sequences in LIC1 (Fig. 1A, line 1);
one of these peptides is at the amino terminus, and the other is within
the relatively divergent portion of the carboxyl terminus (amino acids
400 to the end). The rat LIC1 sequence contains regions corresponding
to all of the peptide sequences we previously obtained from the LIC1
doublet, including the peptide that was found only in DLC-A (Fig.
1A, line 3), thus confirming our hypothesis that
DLC-A is the chicken isoform of LIC1. Both of these sequences contain a
P-loop consensus (Fig. 1A, open boxes at
left) sequence, which has been found to be highly conserved among LICs (see "Discussion"). We note that a LIC1 antiserum
cross-reacted with LIC2, consistent with the high degree of sequence
conservation; surprisingly, an anti-LIC2 serum was monospecific (Fig.
1B).

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 1.
A, line diagram of rat LIC1 and LIC2.
Open boxes at left represent conserved P-loop
sequences. Open boxes labeled A and B
within LIC2 represent alternative splice regions. The short black
lines between the LICs represent the original peptide sequences we
previously reported (15). The two peptides indicated on line
1 are found in LIC2, exclusively. The peptides on line
2 are found in both LIC sequences, and the peptide on line
3 is LIC1-specific. The bracket on line 4 indicates the pericentrin binding region of LIC1. B, COS-7
cell extract was immunoblotted with antiserum raised against rat LIC1
(lane 1) and LIC2 (lane 2).
|
|
We note that during the course of these experiments we also obtained
cDNA clones that indicated there are four alternative LIC2 isoforms
in rat (Fig. 1A, open boxes labeled A
and B); the human LIC2 isoforms have all appeared in
GenBankTM (23). We have obtained no comparable pattern in our LIC1 cDNAs.
LIC1 Specifically Binds to Pericentrin--
Because rat LIC1 and
LIC2 are very highly homologous to each other, we were interested in
potential functional similarities or differences between them. Our
initial analysis of pericentrin binding made use of LIC1, but the
relative ability of different LICs to interact with pericentrin was not
explored (20). Fig. 2 shows
co-immunoprecipitation assays in which HA-pericentrin was overexpressed
with LIC1-myc or LIC2-myc. Anti-HA immunoprecipitates of pericentrin
were probed with anti-myc to detect the LICs. Only LIC1, and not LIC2,
was found to co-immunoprecipitate with pericentrin.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of cytoplasmic dynein LIC1 and
LIC2 co-immunoprecipitation with pericentrin. LIC1-myc
and LIC2-myc were overexpressed alone ( ) or with
HA-pericentrin (+) in COS-7 cells. Resulting cell extracts were used
for anti-HA immunoprecipitations. Precipitates (left) and
supernatants (right) were immunoblotted and probed with
anti-myc to detect the LICs.
|
|
All LICs sequenced to date contain a P-loop consensus sequence,
indicating potential ATPase activity. Because this P-loop is well
conserved from human to Caenorhabditis elegans (see
"Discussion"), it is likely that it plays a functional role in LIC
activities. To test for any effect of ATPase activity on the
LIC1/pericentrin interaction, we constructed two different full-length
LIC1 constructs with point mutations in the P-loop sequence. Because it
is difficult to predict the effects on binding and/or nucleotide
hydrolysis in response to point mutations (24), we tested a mutation of the invariant lysine (K80) to glutamic acid (E) and a mutation of the
threonine (T81) to alanine. Both of these point mutants were used in
the co-immunoprecipitation assay with pericentrin. We were unable to
detect any binding differences between these mutants and wild type LIC1
(Fig. 3, and data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Cytoplasmic dynein LIC1 fragments bind to
pericentrin. Various truncation constructs of LIC1 were
co-expressed with HA-pericentrin. The gray box represents
the P-loop sequence; the X within the boxes
(LIC1TA and LIC1KE) represents point mutations
within the P-loop sequence. On the right + indicates
positive co-immunoprecipitation with HA-pericentrin, and indicates negative co-immunoprecipitation. The black bar
summarizes the deduced pericentrin binding region. Data for several
immunoprecipitations are shown in Figs. 2 and 4.
|
|
To determine whether specific regions within LIC1 and pericentrin were
important in their interaction, we evaluated a series of truncation
mutants of both LIC1 and pericentrin in our co-immunoprecipitation assay. Fig. 3 shows LIC1 truncations in a summary of the results of
co-immunoprecipitation assays using full-length HA-pericentrin (data
for several of these truncations are shown in Figs. 2 and 4). This series of truncations shows that
the region of LIC1 between amino acids 140 and 236 is important in the
interaction. Mutants that contain any part of this region were found to
interact with HA-pericentrin in the assay, whereas mutants that do not
contain any of this region did not interact.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Cytoplasmic dynein LIC1
coimmunoprecipitations with pericentrin fragments. A,
three pericentrin fragments were constructed for
co-immunoprecipitation. The amino acids included in each fragment are
listed at the right; all fragments had amino-terminal HA
tags. B, LIC constructs listed at right were
co-overexpressed with pericentrin constructs listed at the top.
Pericentrin fragments were immunoprecipitated with anti-HA. Anti-myc
was used to probe immunoblots of the precipitations for LIC1-myc
fragments.
|
|
Fig. 4 shows three fragments of pericentrin, the amino-terminal,
central, and carboxyl-terminal portions. The full-length LIC1 would not
co-express with all of the pericentrin fragments, so amino- and
carboxyl-terminal truncated LIC1 fragments were used. We found that
both bind to the central portion of pericentrin, amino acids
764-1341.
The LICs Specify Different Subtypes of Dynein--
In light of the
finding that pericentrin binds to LIC1, but not LIC2, we tested the
ability of LICs to homooligomerize or heterooligomerize. We
overexpressed LIC1-HA with LIC1-myc or LIC2-myc (Fig.
5A). When LIC1-HA was
immunoprecipitated with anti-HA, only LIC1-myc was found to
co-precipitate, indicating that LIC1 forms homooligomers, but not
heterooligomers. Fig. 5B shows that oligomers will also form
from LIC2-myc and LIC2-FLAG. Homooligomers also occurred when the
myc-tagged constructs had point mutations in the P-loop sequences (data
not shown), indicating that a functional P-loop is not required for LIC
self-association. It is not possible for us to tell from these
experiments how many LIC molecules form a homooligomer.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
Cytoplasmic dynein LICs form homooligomers
but not heterooligomers. Supernatants from immunoprecipitations
are shown at the right to verify expression of LIC
fragments. A, LIC1-HA overexpressed in combination with
LIC1-myc and LIC2-myc (indicated at the top) was
immunoprecipitated with anti-HA and immunoblots were probed with
anti-myc. Only LIC1-myc co-precipitated with
LIC1-HA. B, LIC2-myc, which did not
co-precipitate with LIC1-HA, does co-precipitate with LIC2-FLAG.
|
|
We used triple overexpression to determine whether LIC1 and LIC2
homooligomers were present in the same or different dynein complexes
(Fig. 6). LIC1-HA and LIC2-myc were
overexpressed along with C1140-myc, a dynein heavy chain construct that
binds to the LICs (see accompanying article (25)). Fig. 6A
shows the triple overexpression extract immunoprecipitated with both
anti-HA and anti-LIC2. When probed with anti-myc, C1140-myc was found
in both immunoprecipitates, but LIC2-myc was only found in anti-LIC2
and not in anti-HA precipitations. Fig. 6B shows the same
blots reprobed with anti-HA to localize LIC1-HA. LIC1-HA is found only
in anti-HA and not in anti-LIC2 immunoprecipitations. This experiment
demonstrates that each LIC independently associates with HC; LIC1 and
LIC2 do not bind to HC simultaneously.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Cytoplasmic dynein HC does not bind to LIC1
and LIC2 simultaneously. A, extracts overexpressing the
HC carboxyl terminus (HC-C1140-myc), LIC2-myc, and LIC1-HA were
immunoprecipitated with anti-HA (left lanes) and anti-LIC2
(right lanes); cell extracts are shown in the center
lanes. Immunoblots were probed with anti-myc. B, the
same blots from A were reprobed with anti-HA. In the
right-hand section, there is a nonspecific smudge that
appeared upon overexposure of the blot; no specific LIC1 band was seen
in that panel.
|
|
Finally, we tested our hypothesis that there are two different dynein
populations by looking at the endogenous LICs that co-precipitate with
overexpressed pericentrin. Our previous work has shown that overexpressed pericentrin will precipitate endogenous dynein HC and IC.
LIC content has not been demonstrated due to technical difficulties
caused by the similar molecular weights of the LICs and the antibody
heavy chain. To avoid this problem, we eluted anti-HA precipitations
with sample buffer lacking -mercaptoethanol (Fig.
7), which kept the antibody intact, so
that it did not interfere with the LICs. As predicted, endogenous LIC1
co-precipitated with pericentrin, but LIC2 was not detected,
demonstrating the existence of a subpopulation of dynein, which
contains only LIC1.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 7.
Overexpressed pericentrin co-precipitates
endogenous LIC1 but not LIC2. Extracts overexpressing pericentrin
were immunoprecipitated with anti-HA or beads alone (left
panel). Immunoblots were probed with pan-anti-LIC antibody to
determine the LIC content of co-precipitating dynein. Supernatants are
shown on the right for comparison.
|
|
 |
DISCUSSION |
We have identified a second LIC gene in rat, confirming our
earlier hypothesis (15) and further accounting for the considerable diversity in LIC forms observed in purified cytoplasmic dynein complexes. We have also demonstrated that LIC1 is specific for pericentrin binding and that the LICs form homooligomers, but not
heterooligomers. Through triple overexpression studies, we have shown
that the two LIC isoforms cannot bind to HC simultaneously. These
results together provide evidence for the existence of functionally distinct cytoplasmic dynein complexes that differ by LIC content.
LIC Sequences--
From comparisons of rat LIC2 and chicken DLC-A
sequences we previously hypothesized the existence of two different but
related LIC genes in rat (15). The amino acid sequences of LIC1 and LIC2 differ throughout the entire length, and the DNA sequences are
only 68% identical, with no large (>30 nucleotides) stretches of
complete identity, supporting the idea that they are derived from
different genes. LIC1 and LIC2 amino acid sequences account for all 11 peptide sequences that we obtained from bovine cytoplasmic dynein LICs
(15), suggesting that there are no additional LIC genes.
BLAST searches of the C. elegans genome, which is nearly
complete, with either LIC sequence yield only one match. The gene product is an LIC that is equally homologous to both LIC1 and LIC2.
These results suggest that C. elegans has only one LIC gene. Because the full range of LIC functions is not known in any species, it
remains to be seen whether a single LIC in C. elegans can
carry out all LIC functions or if the diversity provided by two
separate vertebrate LICs allows for additional roles for this class of subunit. Despite relatively low homology between rat and worm sequences, the C. elegans LIC has a conserved P-loop
sequence, further suggesting that the LICs are functional ATPases. No
sequences homologous to LIC have been found in the S. cerevisiae genome, apparently indicating that LIC is not involved
in the limited functions attributed to yeast dynein. It is also
interesting to note that the LICs have not appeared among nuclear
migration mutants of Aspergillus nidulans (the nud mutants)
(26, 27) and Neurospora crassa (the ropy mutants) (28). All
other dynein subunit classes and some dynactin subunits have been
identified in the screening of these mutants, suggesting that the LICs
may not be involved in nuclear migration.
LIC1/Pericentrin Interaction--
The isoform specificity of
pericentrin binding that we describe here adds strong support for the
specificity of the LIC-pericentrin interaction. The interaction site
(amino acid 140-236 of LIC1) is bracketed in Fig. 1A. This
region shows a high degree of identity between LIC1 and LIC2 except for
amino acids 201-219, which appears to be isoform-specific. This region
may account for the binding specificity of LIC1.
The P-loop sequence of LIC1 is located amino-terminal to the
interaction region. Mutations in the P-loop do not appear to have any
obvious effect on the LIC1/pericentrin interaction. Some fragments of
LIC1 bind more efficiently to pericentrin than full-length LIC1 does;
for example, LIC1N174 and LIC1C173 each contain part of the interacting
region, and each co-immunoprecipitate with pericentrin more efficiently
than full-length LIC1. The most likely explanation for this observation
is that when LIC1 is truncated, regulatory elements are removed,
allowing for maximum binding between LIC1 and pericentrin. Conversely,
the pericentrin fragment that binds to LIC1 does not bind any better
than full-length pericentrin, suggesting that any regulation of the
interaction occurs with LIC1, rather than pericentrin. We would expect
the LIC1/pericentrin interaction to be highly regulated to allow for
the slow accumulation and rapid dissociation of pericentrin at the centrosome.
-Tubulin has been found to co-immunoprecipitate with and accumulate
at the centrosome with pericentrin (17). -Tubulin does not associate
with the central portion of
pericentrin,2 in contrast to
LIC1 (Fig. 4). This suggests that pericentrin may be capable of
associating with LIC1 (and thus dynein) and the -tubulin containing
-tubulin ring complex at the same time. This would allow for
the -TURC complex to be transported to the centrosome at the same
time as pericentrin, without any components of the complex directly
binding to dynein.
Significance of Dynein Subtypes--
Our findings that only LIC1
binds to pericentrin and that LIC1 and LIC2 binding to HC is mutually
exclusive suggest that a substantial subfraction of dynein is incapable
of binding to pericentrin. In other work (see accompanying manuscript),
we have demonstrated that the LIC1 and LIC2 binding sites on the HC are
identical, further supporting our contention that the LICs bind to the
HC, and thus the complex, mutually exclusively to define functional subfractions of dynein. LIC1-containing dynein can bind to pericentrin, whereas LIC2 dynein cannot, and there may be LIC-less dynein that also
cannot. This adds diversity to the pool of dynein in the cell. The
subcellular targeting of dynein may be simplified by the existence of
dynein subtypes, each of which is responsible for a given set of dynein
functions. Pericentrin binding is likely to be one of several functions
of LIC1, because there appears to be considerably more LIC1 than
pericentrin in cells. This suggests that other mechanisms are still
required for the specific binding of dynein to various cellular
components, but alternative LIC subunit content provides some amount of specificity.
We have speculated that the LICs may be responsible for a
non-dynactin-based targeting mechanism for dynein, perhaps specific for
soluble proteins rather than membrane-bound organelles (20). In this
view, The LICs would function independently of dynactin, with each
having different targeting specificities. Dynactin-mediated targeting
of dynein would, presumably, involve either a subfraction of dynein,
which lacks LICs or in which the LICs have been inactivated. However,
given that p50 overexpression has been observed to disrupt the
accumulation of pericentrin at centrosomes (16), it is also quite
possible that dynactin and the LICs function in concert in certain
situations to support both binding and motility. Further work is
necessary to determine the actual relationship between LIC- and
dynactin-mediated functions.
 |
ACKNOWLEDGEMENT |
We thank Dr. Elizabeth Luna for her assistance
in using 5' rapid amplification of cDNA ends to complete the 5'-end
of the LIC1 cDNA.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants GM47434 (to R. B. V.) and GM51994 (to S. J. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF181992.
¶
To whom correspondence should be addressed: Dept. of Cell
Biology, University of Massachusetts Medical Center, 377 Plantation St., Worcester, MA 01605. Tel.: 508-856-8504; Fax: 508-856-8987; E-mail: Richard.vallee@umassmed.edu.
Published, JBC Papers in Press, July 11, 2000, DOI 10.1074/jbc.M001536200
2
W. Zimmerman and S. Doxsey, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
HC, heavy chain
subunit;
IC, intermediate chain subunit;
LIC, light intermediate chain
subunit;
LC, light chain subunit;
PCR, polymerase chain reaction;
HA, hemagglutinin.
 |
REFERENCES |
| 1.
|
Paschal, B. M.,
and Vallee, R. B.
(1987)
Nature
330,
181-183
|
| 2.
|
Vallee, R. B.,
and Sheetz, M. P.
(1996)
Science
271,
1539-1544
|
| 3.
|
Steuer, E. R.,
Wordeman, L.,
Schroer, T. A.,
and Sheetz, M. P.
(1990)
Nature
345,
266-268
|
| 4.
|
Pfarr, C. M.,
Coue, M.,
Grissom, P. M.,
Hays, T. S.,
Porter, M. E.,
and McIntosh, J. R.
(1990)
Nature
345,
263-265
|
| 5.
|
Busson, S.,
Dujardin, D.,
Moreau, A.,
Dompierre, J.,
and De Mey, J. R.
(1998)
Curr. Biol.
8,
541-544
|
| 6.
|
Gonczy, P.,
Pichler, S.,
Kirkham, M.,
and Hyman, A. A.
(1999)
J. Cell Biol.
147,
135-150
|
| 7.
|
Echeverri, C. J.,
Paschal, B. M.,
Vaughan, K. T.,
and Vallee, R. B.
(1996)
J. Cell Biol.
132,
617-633
|
| 8.
|
Vaughan, K. T.,
and Vallee, R. B.
(1995)
J. Cell Biol.
131,
1507-1516
|
| 9.
|
Karki, S.,
and Holzbaur, E. L.
(1995)
J. Biol. Chem.
270,
28806-28811
|
| 10.
|
King, S. M.,
Dillman, J. F., III,
Benashski, S. E.,
Lye, R. J.,
Patel-King, R. S.,
and Pfister, K. K.
(1996)
J. Biol. Chem.
271,
32281-32287
|
| 11.
|
Harrison, A.,
Olds-Clarke, P.,
and King, S. M.
(1998)
J. Cell Biol.
140,
1137-1147
|
| 12.
|
Bowman, A. B.,
Patel-King, R. S.,
Benashski, S. E.,
McCaffery, J. M.,
Goldstein, L. S.,
and King, S. M.
(1999)
J. Cell Biol.
146,
165-180
|
| 13.
|
Tai, A. W.,
Chuang, J. Z.,
Bode, C.,
Wolfrum, U.,
and Sung, C. H.
(1999)
Cell
97,
877-887
|
| 14.
|
Gill, S. R.,
Cleveland, D. W.,
and Schroer, T. A.
(1994)
Mol. Biol. Cell
5,
645-654
|
| 15.
|
Hughes, S. M.,
Vaughan, K. T.,
Herskovits, J. S.,
and Vallee, R. B.
(1995)
J. Cell Sci.
108,
17-24
|
| 16.
|
Young, A.,
Dictenberg, J.,
Purohit, A.,
Tuft, R.,
and Doxsey, S. J.
(2000)
Mol. Biol. Cell
11,
2047-2056
|
| 17.
|
Dictenberg, J. B.,
Zimmerman, W.,
Sparks, C. A.,
Young, A.,
Vidair, C.,
Zheng, Y.,
Carrington, W.,
Fay, F. S.,
and Doxsey, S. J.
(1998)
J. Cell Biol.
141,
163-174
|
| 18.
|
Khodjakov, A.,
and Rieder, C. L.
(1999)
J. Cell Biol.
146,
585-596
|
| 19.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
|
| 20.
|
Purohit, A.,
Tynan, S. H.,
Vallee, R.,
and Doxsey, S. J.
(1999)
J. Cell Biol.
147,
481-492
|
| 21.
|
Doxsey, S. J.,
Stein, P.,
Evans, L.,
Calarco, P. D.,
and Kirschner, M.
(1994)
Cell
76,
639-650
|
| 22.
|
Gee, M. A.,
Heuser, J. E.,
and Vallee, R. B.
(1997)
Nature
390,
636-639
|
| 23.
|
Maeda, S.,
Nam, S. Y.,
Fujisawa, M.,
Nakamuta, N.,
Ogawa, K.,
Kurohmaru, M.,
and Hayashi, Y.
(1998)
Cell Struct. Funct.
23,
169-178
|
| 24.
|
Saraste, M.,
Sibbald, P. R.,
and Wittinghofer, A.
(1990)
Trends Biochem. Sci.
15,
430-434
|
| 25.
|
Tynan, S. H.,
Purohit, A.,
Doxsey, S. J.,
and Vallee, R. B.
(2000)
J. Biol. Chem.
275,
32769-32774
|
| 26.
|
Morris, N. R.
(1976)
Exp. Cell Res.
98,
204-210
|
| 27.
|
Xiang, X.,
Beckwith, S. M.,
and Morris, N. R.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2100-2104
|
| 28.
|
Plamann, M.,
Minke, P. F.,
Tinsley, J. H.,
and Bruno, K. S.
(1994)
J. Cell Biol.
127,
139-149
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Ha, K. W.-H. Lo, K. R. Myers, T. M. Carr, M. K. Humsi, B. A. Rasoul, R. A. Segal, and K. K. Pfister
A neuron-specific cytoplasmic dynein isoform preferentially transports TrkB signaling endosomes
J. Cell Biol.,
October 21, 2008;
181(6):
1027 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W.-H. Lo, J. M. Kogoy, B. A. Rasoul, S. M. King, and K. K. Pfister
Interaction of the DYNLT (TCTEX1/RP3) Light Chains and the Intermediate Chains Reveals Novel Intersubunit Regulation during Assembly of the Dynein Complex
J. Biol. Chem.,
December 21, 2007;
282(51):
36871 - 36878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Stehman, Y. Chen, R. J. McKenney, and R. B. Vallee
NudE and NudEL are required for mitotic progression and are involved in dynein recruitment to kinetochores
J. Cell Biol.,
August 9, 2007;
178(4):
583 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Williams, P. L. Roulhac, A. G. Roy, R. B. Vallee, M. C. Fitzgerald, and W. A. Hendrickson
Structural and thermodynamic characterization of a cytoplasmic dynein light chain intermediate chain complex
PNAS,
June 12, 2007;
104(24):
10028 - 10033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Haghnia, V. Cavalli, S. B. Shah, K. Schimmelpfeng, R. Brusch, G. Yang, C. Herrera, A. Pilling, and L. S.B. Goldstein
Dynactin Is Required for Coordinated Bidirectional Motility, but Not for Dynein Membrane Attachment
Mol. Biol. Cell,
June 1, 2007;
18(6):
2081 - 2089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Kim, M. Takahashi, K. Matsuo, and Y. Ono
Recruitment of CG-NAP to the Golgi apparatus through interaction with dynein-dynactin complex
Genes Cells,
March 1, 2007;
12(3):
421 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W.-H. Lo, H.-M. Kan, and K. K. Pfister
Identification of a Novel Region of the Cytoplasmic Dynein Intermediate Chain Important for Dimerization in the Absence of the Light Chains
J. Biol. Chem.,
April 7, 2006;
281(14):
9552 - 9559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Li, C. E. Oakley, G. Chen, X. Han, B. R. Oakley, and X. Xiang
Cytoplasmic Dynein's Mitotic Spindle Pole Localization Requires a Functional Anaphase-promoting Complex, {gamma}-Tubulin, and NUDF/LIS1 in Aspergillus nidulans
Mol. Biol. Cell,
August 1, 2005;
16(8):
3591 - 3605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-L. Lee, M. A. Kaiser, and J. A. Cooper
The offloading model for dynein function: differential function of motor subunits
J. Cell Biol.,
January 17, 2005;
168(2):
201 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hou, G. J. Pazour, and G. B. Witman
A Dynein Light Intermediate Chain, D1bLIC, Is Required for Retrograde Intraflagellar Transport
Mol. Biol. Cell,
October 1, 2004;
15(10):
4382 - 4394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Zimmerman, J. Sillibourne, J. Rosa, and S. J. Doxsey
Mitosis-specific Anchoring of {gamma} Tubulin Complexes by Pericentrin Controls Spindle Organization and Mitotic Entry
Mol. Biol. Cell,
August 1, 2004;
15(8):
3642 - 3657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-g. Li, M. Serr, E. A. Newman, and T. S. Hays
The Drosophila tctex-1 Light Chain Is Dispensable for Essential Cytoplasmic Dynein Functions but Is Required during Spermatid Differentiation
Mol. Biol. Cell,
July 1, 2004;
15(7):
3005 - 3014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chen, A. Purohit, E. Halilovic, S. J. Doxsey, and A. C. Newton
Centrosomal Anchoring of Protein Kinase C {beta}II by Pericentrin Controls Microtubule Organization, Spindle Function, and Cytokinesis
J. Biol. Chem.,
February 6, 2004;
279(6):
4829 - 4839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Perrone, D. Tritschler, P. Taulman, R. Bower, B. K. Yoder, and M. E. Porter
A Novel Dynein Light Intermediate Chain Colocalizes with the Retrograde Motor for Intraflagellar Transport at Sites of Axoneme Assembly in Chlamydomonas and Mammalian Cells
Mol. Biol. Cell,
May 1, 2003;
14(5):
2041 - 2056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Schafer, C. J. Haycraft, J. H. Thomas, B. K. Yoder, and P. Swoboda
XBX-1 Encodes a Dynein Light Intermediate Chain Required for Retrograde Intraflagellar Transport and Cilia Assembly in Caenorhabditis elegans
Mol. Biol. Cell,
May 1, 2003;
14(5):
2057 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, S. Li, R. Fischer, and X. Xiang
Accumulation of Cytoplasmic Dynein and Dynactin at Microtubule Plus Ends in Aspergillus nidulans Is Kinesin Dependent
Mol. Biol. Cell,
April 1, 2003;
14(4):
1479 - 1488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. M. Boylan and T. S. Hays
The Gene for the Intermediate Chain Subunit of Cytoplasmic Dynein Is Essential in Drosophila
Genetics,
November 1, 2002;
162(3):
1211 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|